Whether ANRIL expression correlates with IL6, CCL2, and POSTN in breast tumors was also investigated to provide evidence of how ANRIL may contribute to inflammation in breast cancer (20–22). This evidence concerns the gene CDKN2B-AS1 and breast cancer.